Jun 07,2021

Voluntis receives FDA 510(k) clearance for a new version of Insulia supporting an expanded range of basal insulins

Voluntis (Euronext Growth Paris, Ticker: ALVTX – ISIN: FR0004183960)a leader in digital therapeutics, today announced that it has received the FDA 510(k) clearance for a new version of Insulia supporting an additional basal insulin product, expanding the scope of insulins covered by the solution. Voluntis’ flagship diabetes digital therapeutic, Insulia, helps people with type 2 diabetes with dose titration. It is indicated for patients with type 2 diabetes initiating or uncontrolled on basal insulin, treated with a wide range of basal insulin analogues, including all approved insulin glargines.

PRODUCT

#mobile app

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 07,2021

Epillo launches integrated solutions for patients and clinicians in Asia, US

Estonia-based digital therapeutics company Epillo Health Systems has launched its latest line of clinical solutions. It comprises EHR systems for clinics and pharmacies and a mobile app for patients, which is now available in Singapore, Malaysia, India and the US. The web-based INTRx Clinical system helps clinicians manage patient portfolio and health with features such as e-prescribing, teleconsultations, patient coordinated care, monitoring and analytics, diet and lab tests, among others. It also handles administrative and financial workflows, as well as appointments.

PRODUCT

#mobile app

#telehealth

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 10,2021

One Drop Surpasses 25 Billion Biometric Data Points, Accelerating Expansion Of Its Precision Health Platform

One Drop, a leader in precision health solutions for people living with chronic conditions worldwide, today announced it has surpassed 25 billion longitudinal biometric data points powering its precision health platform. This milestone accompanies an increase in accuracy of One Drop's outcomes forecasts, presented at the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2021).

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 22,2021

Exclusive negotiations regarding a potential acquisition of Voluntis by Aptar to expand in digital therapeutics

Voluntis (Euronext Growth Paris, Ticker: ALVTX – ISIN: FR0004183960), a leader in digital therapeutics, and its main shareholders announced today that they have entered into exclusive negotiations with AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, with respect to a potential acquisition of all outstanding shares of Voluntis by Aptar.

#rpm

#software

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 14,2021

Integra Community Care Network Partners with Biofourmis to Deliver Personalized Care at Home

Biofourmis, a Boston-based global leader in digital medicine and virtual care that powers personalized predictive care, announced today a partnership with Integra Community Care Network, Care New England’s accountable care organization (ACO). Integra, one of the largest ACOs in New England, will deliver hospital at home care and remote patient monitoring through Biofourmis’ end-to-end solution.

PRODUCT

#virtual care

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 01,2021

DarioHealth Gathers Momentum in the Provider Market with Two New Contracts for Remote Patient Monitoring Services

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into contracts with two prominent regional providers in Hawaii and Georgia for its Remote Patient Monitoring (RPM) services. Both partnerships will provide RPM services for patients living with diabetes and hypertension, two of the most common – and commonly co-occurring - chronic conditions.

PRODUCT

#rpm

#software

View Analyst & Ambassador Comments
Go to original news
Nov 11,2021

DarioHealth Announces Three New Contracts as Growth Continues to Accelerate Across the Employer and Provider Markets

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two new employers and a new provider partner channel to provide the Company's digital therapeutic solutions beginning in the first quarter of 2022. The new employer clients include a southwest regional employer in the health care industry contracting for behavioral health, and a midwestern employer in the food industry contracting for behavioral health with Employee Assistance Programs (EAPs). The new provider contract gives Dario access to a wide range of providers through a unique strategic partnership that will launch with Dario's Remote Patient Monitoring (RPM) solution for hypertension in one practice in California, before expanding access to additional practices throughout 2022.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Dec 13,2021

NuvoAir Sensor Expands Possibilities for Asthma and COPD Control

NuvoAir, a rapidly growing digital health company that recently landed Series A funding, has released an add-on sensor for asthma and chronic obstructive pulmonary disease (COPD) inhalers as a part of its chronic care ecosystem. The NuvoAir Aos sensor brings additional data to the service platform enabling NuvoAir Care Coordinators and healthcare providers to assess inhaler technique, monitor inhaler use and evaluate treatment effectiveness.

PRODUCT

#connected device

#rpm

View Analyst & Ambassador Comments
Go to original news
Dec 13,2021

Biofourmis Wins Two 2021 Fierce Healthcare Innovation Awards for Hospital@Home Solution

Biofourmis, a Boston-based global leader in digital medicine and virtual care that powers personalized predictive care, today announced that its Hospital@Home solution has been named by Fierce Healthcare as the Digital/Mobile Health Solution Winner and Best in Show Winner for Cost Saving in the Fierce Healthcare Innovation Awards 2021.

PRODUCT

#rpm

#mobile app

#virtual care

View Analyst & Ambassador Comments
Go to original news
Dec 22,2021

2022 forecast: The next hot areas for digital health investing

Here are five digital health markets to watch as investors look to pour major cash into the healthcare sector.

#virtual care

#rpm

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Subscribe to RPM